The effects of a diet based on Iranian medicine on COVID-19 patients
Phase 3
- Conditions
- new Corona virus disease 2019.new Corona virus disease 2019U07.1
- Registration Number
- IRCT20220227054140N1
- Lead Sponsor
- Artesh University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Patients who have positive PCR for COVID-19
Patients with COVID-19 who have been admitted to hospital
Exclusion Criteria
Patients who are pregnant or breastfeeding
Patients with underlying diseases such as: diabetes, hypertension and cancer
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ICU admission or intubation. Timepoint: During hospitalization, daily. Method of measurement: Evaluator report.
- Secondary Outcome Measures
Name Time Method Clinical symptoms (cough intensity, The degree of shortness of breath). Timepoint: During hospitalization, daily. Method of measurement: Symptoms by asking the patient as a scale indicator and signs by monitoring the patient by the assessor.;Inflammatory markers (ESR, CRP, LDH, WBC). Timepoint: before and after the 5 days intervention. Method of measurement: Quantitative laboratory measurements of blood samples.;Clinical examinations (RR, SO2). Timepoint: During hospitalization, daily. Method of measurement: Through clinical examination and use of pulse oximeter.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the effects of Iranian traditional medicine diet on SARS-CoV-2 viral load and immune response in phase III trials?
How does a diet based on Iranian medicine compare to standard nutritional guidelines in improving clinical outcomes for moderate to severe COVID-19 patients?
Which biomarkers are associated with favorable response to Iranian traditional medicine dietary interventions in U07.1 disease classification patients?
What adverse events have been reported in phase III trials of traditional medicine-based diets for managing SARS-CoV-2 infections?
Are there synergistic effects when combining Iranian traditional medicine diet with antiviral therapies like remdesivir in treating COVID-19?